The Economic Burden of Diabetic Retinopathy in Jordan: Cost Analysis and Associated Factors

References

• Klein BE. Overview of epidemiologic studies of diabetic retinopathy. Ophthalmic Epidemiol. 2007;14(4):179–183. doi:10.1080/09286580701396720
   PubMed Web of Science ®Google Scholar
• Klein R, Klein BE, Moss SE. Visual impairment in diabetes. Ophthalmology. 1984;91(1):1–9. doi:10.1016/S0161-6420(84)34337-8
   PubMed Web of Science ®Google Scholar
• Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet. 2010;376(9735):124–136. doi:10.1016/S0140-6736(09)62124-3
   PubMed Web of Science ®Google Scholar
• Al-Dwairi R, Rwashdeh H, Otoom M. The Influence of COVID-19 Lockdown in Jordan on Patients with Diabetic Retinopathy: a Case-Control Study. Therapeutics Clin Risk Management. 2021;17:1011–1022. doi:10.2147/TCRM.S316265
   PubMed Web of Science ®Google Scholar
• Al-Amer RM, Khader Y, Malas S, Abu-Yaghi N, Al-Bdour M, Ajlouni K. Prevalence and risk factors of diabetic retinopathy among Jordanian patients with type 2 diabetes. Digital j Ophthalmol. 2008;14:42–49. doi:10.5693/djo.01.2008.013
   PubMedGoogle Scholar
• Kempen JH, O’Colmain BJ, Leske MC, et al. The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol. 2004;122(4):552–563.
   PubMed Web of Science ®Google Scholar
• Matz H, Falk M, Göttinger W, Kieselbach G. Cost-benefit analysis of diabetic eye disease. Ophthalmologica J Int. 1996;210(6):348–353. doi:10.1159/000310742
   PubMed Web of Science ®Google Scholar
• Zhang X, Saaddine JB, Chou CF, et al. Prevalence of diabetic retinopathy in the United States, 2005-2008. JAMA. 2010;304(6):649–656. doi:10.1001/jama.2010.1111
   PubMed Web of Science ®Google Scholar
• Early Treatment Diabetic Retinopathy Study Research Group. Focal photocoagulation treatment of diabetic macular edema. Relationship of treatment effect to fluorescein angiographic and other retinal characteristics at baseline: ETDRS report no. 19. Arch Ophthalmol. 1995;113(9):1144–1155. doi:10.1001/archopht.1995.01100090070025
   PubMedGoogle Scholar
• Drummond MF, Davies LM, Ferris FL. Assessing the costs and benefits of medical research: the diabetic retinopathy study. Soc sci med. 1992;34(9):973–981. doi:10.1016/0277-9536(92)90128-D
   PubMed Web of Science ®Google Scholar
• Kohner EM, Porta M. Protocols for screening and treatment of diabetic retinopathy in Europe. Eur j Ophthalmol. 1991;1(1):45–54. doi:10.1177/112067219100100109
   PubMedGoogle Scholar
• Rein DB, Zhang P, Wirth KE, et al. The economic burden of major adult visual disorders in the United States. Arch Ophthalmol. 2006;124(12):1754–1760. doi:10.1001/archopht.124.12.1754
   PubMedGoogle Scholar
• Kirkizlar E, Serban N, Sisson JA, Swann JL, Barnes CS, Williams MD. Evaluation of telemedicine for screening of diabetic retinopathy in the Veterans Health Administration. Ophthalmology. 2013;120(12):2604–2610. doi:10.1016/j.ophtha.2013.06.029
   PubMed Web of Science ®Google Scholar
• Wilkinson CP, Ferris FL, Klein RE, et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology. 2003;110(9):1677–1682. doi:10.1016/S0161-6420(03)00475-5
   PubMed Web of Science ®Google Scholar
• Schulze-Bonsel K, Feltgen N, Burau H, Hansen L, Bach M. Visual Acuities “Hand Motion” and “Counting Fingers” Can Be Quantified with the Freiburg Visual Acuity Test. Invest Ophthalmol Visual Sci. 2006;47(3):1236–1240. doi:10.1167/iovs.05-0981
   PubMed Web of Science ®Google Scholar
• Happich M, Reitberger U, Breitscheidel L, Ulbig M, Watkins J. The economic burden of diabetic retinopathy in Germany in 2002. Graefe’s Arch Clin Exp Ophthalmol. 2008;246(1):151–159. doi:10.1007/s00417-007-0573-x
   PubMed Web of Science ®Google Scholar
• Schmitt-Koopmann I, Schwenkglenks M, Spinas GA, Szucs TD. Direct medical costs of type 2 diabetes and its complications in Switzerland. Eur j Public Health. 2004;14(1):3–9. doi:10.1093/eurpub/14.1.3
   PubMed Web of Science ®Google Scholar
• Schmier JK, Covert DW, Lau EC, Matthews GP. Medicare expenditures associated with diabetes and diabetic retinopathy. Retina. 2009;29(2):199–206. doi:10.1097/IAE.0b013e3181884f2d
   PubMed Web of Science ®Google Scholar
• Lee LJ, Yu AP, Cahill KE, et al. Direct and indirect costs among employees with diabetic retinopathy in the United States. Curr Med Res Opin. 2008;24(5):1549–1559. doi:10.1185/030079908X297303
   PubMed Web of Science ®Google Scholar
• Khattab M, Khader YS, Al-Khawaldeh A, Ajlouni K. Factors associated with poor glycemic control among patients with type 2 diabetes. J diabet complicat. 2010;24(2):84–89. doi:10.1016/j.jdiacomp.2008.12.008
   Google Scholar
• Al-Rasheedi AA. Glycemic Control among Patients with Type 2 Diabetes Mellitus in Countries of Arabic Gulf. Int j Health Sci. 2015;9(3):345–350. doi:10.12816/0024701
   PubMedGoogle Scholar
• Noureddine H, Nakhoul N, Galal A, Soubra L, Saleh M. Level of A1C control and its predictors among Lebanese type 2 diabetic patients. Therapeutic Adv Endocrinology Metab. 2014;5(3):43–52. doi:10.1177/2042018814544890
   PubMedGoogle Scholar
• Janghorbani M, Amini M. Patterns and predictors of long-term glycemic control in patients with type 2 diabetes. ISRN endocrinol. 2012;2012:526824. doi:10.5402/2012/526824
   PubMedGoogle Scholar
• Gross JG, Glassman AR, Jampol LM, et al. Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: a Randomized Clinical Trial. JAMA. 2015;314(20):2137–2146. doi:10.1001/jama.2015.15217
   PubMed Web of Science ®Google Scholar
• Rajendram R, Fraser-Bell S, Kaines A, et al. A 2-year prospective randomized controlled trial of intravitreal bevacizumab or laser therapy (BOLT) in the management of diabetic macular edema: 24-month data: report 3. Arch Ophthalmol. 2012;130(8):972–979. doi:10.1001/archophthalmol.2012.393
   PubMed Web of Science ®Google Scholar
• Wells JA, Glassman AR, Ayala AR, et al. Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema: two-Year Results from a Comparative Effectiveness Randomized Clinical Trial. Ophthalmology. 2016;123(6):1351–1359. doi:10.1016/j.ophtha.2016.02.022
   PubMed Web of Science ®Google Scholar
• The Diabetic Retinopathy Study Research Group. Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS Report Number 8. Ophthalmology. 1981;88(7):583–600.
   PubMed Web of Science ®Google Scholar
• The Diabetic Retinopathy Vitrectomy Study Research Group. Early vitrectomy for severe proliferative diabetic retinopathy in eyes with useful vision. Results of a randomized trial--Diabetic Retinopathy Vitrectomy Study Report 3. Ophthalmology. 1988;95(10):1307–1320. doi:10.1016/S0161-6420(88)33015-0
   PubMed Web of Science ®Google Scholar
• Thompson JT, de Bustros S, Michels RG, Rice TA. Results and prognostic factors in vitrectomy for diabetic traction retinal detachment of the macula. Arch Ophthalmol. 1987;105(4):497–502. doi:10.1001/archopht.1987.01060040067035
   PubMedGoogle Scholar
• Zhang X, Low S, Kumari N, et al. Direct medical cost associated with diabetic retinopathy severity in type 2 diabetes in Singapore. PLoS One. 2017;12(7):56.
   Web of Science ®Google Scholar
• Orji A, Rani PK, Narayanan R, Sahoo NK, Das T. The economic burden of diabetic retinopathy care at a tertiary eye care center in South India. Indian j Ophthalmol. 2021;69(3):666–670. doi:10.4103/ijo.IJO_1538_20
   PubMed Web of Science ®Google Scholar
• Parker ED, Lin J, Mahoney T, et al. Economic Costs of Diabetes in the U.S. Diabetes Care. 2023.
   Google Scholar
• Kalyani G, Janakiramaiah B, Karuna A, Prasad LVN. Diabetic retinopathy detection and classification using capsule networks. Complex Intelligent Syst. 2023;9(3):2651–2664. doi:10.1007/s40747-021-00318-9
   Web of Science ®Google Scholar
• Bhandari S, Pathak S, Jain S. A Literature Review of Early-Stage Diabetic Retinopathy Detection Using Deep Learning and Evolutionary Computing Techniques. Arch Comput Methods Eng. 2022;30.
   Web of Science ®Google Scholar
• Vij R, Arora S. A Systematic Review on Diabetic Retinopathy Detection Using Deep Learning Techniques. Arch Comput Methods Eng. 2022;30.
   Web of Science ®Google Scholar
• Özbay E. An Active Deep Learning Method for Diabetic Retinopathy Detection in Segmented Fundus Images Using Artificial Bee Colony Algorithm. Artif Intell Rev. 2022;56.
   Web of Science ®Google Scholar
• Selvachandran G, Quek SG, Paramesran R, Ding W, Son LH. Developments in the detection of diabetic retinopathy: a state-of-The-art review of computer-aided diagnosis and machine learning methods. Artif Intell Rev. 2023;56(2):915–964. doi:10.1007/s10462-022-10185-6
   PubMed Web of Science ®Google Scholar
• Ng CS, Lee JY, Toh MP, Ko Y. Cost-of-illness studies of diabetes mellitus: a systematic review. Diabetes Res Clin Pract. 2014;105(2):151–163. doi:10.1016/j.diabres.2014.03.020
   PubMed Web of Science ®Google Scholar